<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=182969788831632&amp;ev=PageView&amp;noscript=1">

3 min read

Pathology News Roundup: January 31, 2025

Pathology News Roundup: January 31, 2025

Article Touts Generative AI in Pathology. Generative artificial intelligence (GAI) is emerging as a powerful tool across medicine, with the potential to enhance diagnostic accuracy, streamline workflows, and support education and research. A new article, “Generative Artificial Intelligence in Anatomic Pathology,” published in the Archives of Pathology & Laboratory Medicine, explores the significant promise the technology has in the various domains of anatomic pathology.

Screenshot 2025-01-30 093450

The journal article is the fifth and final in a series of papers about GAI in pathology by members of the College of American Pathologists, Digital Pathology Association, and Association for Pathology Informatics.  

“Pathology is entering a new era, where generative AI doesn’t just have the potential to assist pathologists — it should be able to efficiently amplify their expertise, transforming how diseases are diagnosed, treated, and understood,” said Victor Brodsky, MD, who is a lead author.  

GAI offers advanced image analysis, providing clearer insights into tissue and cell structures. This can improve diagnostic accuracy and patient outcomes, especially in cancer care. 

The article also discusses challenges such as bias, data privacy, and the need for thorough validation. Ethical and regulatory considerations are crucial as GAI becomes part of clinical workflows. Collaboration among pathologists, data scientists, and policymakers is essential for safe and effective GAI integration. 

“Generative AI offers exciting possibilities, but it’s important to adopt it thoughtfully and implement continuous validation to maintain trust and high standards of patient care in the coming age of ubiquitous AI agents,” said Dr. Brodsky. 

As the final installment in a series on GAI in pathology, the discussion highlights the importance of interdisciplinary collaboration. By addressing challenges and using GAI responsibly, pathology can advance diagnostic precision, improve patient outcomes, and enhance health care delivery. 

Read the full article in the Archives of Pathology & Laboratory Medicine online. Check out the previous GAI articles in this series on the CAP website.

VB Divider

Top Pathology Issues in 2025. The College of American Pathologists (CAP) outlined its top health care priority issues in a communication to President Donald Trump and leaders of the 119th Congress to help pathologists and laboratories improve patient care and meet challenges in the new year.

The CAP hopes to collaborate with the Trump Administration and the 119th Congress to enhance the nation’s health care system by addressing what it sees as six critical policy and regulatory issues impacting the delivery of high-quality diagnostic services:

  1. Streamline Laboratory Regulations and Reduce Administrative Burden
    The CAP wants leaders to rescind what it calls "the Food and Drug Administration’s arbitrary and capricious Final Rule on laboratory-developed tests (LDTs) and ensure patient access to critical diagnostic tests using a risk-based regulatory framework for LDTs and focused updates to existing regulations."
  2. Ensure Sustainable, Appropriate Reimbursement for Pathology and Laboratory Services
    Stabilize the Medicare payment system to protect access to essential pathology services and mitigate cuts that threaten laboratory operations.
  3. Strengthen the Pathology and Laboratory Workforce
    Address critical workforce shortages by expanding physician training programs and the number of federally supported training slots for pathologists to meet growing patient care demands and the health care needs of an aging population.
  4. Increase Competition and Oversight in Private Payor Health Insurance
    Promote fair insurance practices by ensuring network adequacy, prohibiting anticompetitive contracts, and supporting locally coordinated care.
  5. Finalize Protections Around Surprise Billing and Price Transparency
    Streamline billing dispute processes and implement good faith estimate requirements to protect patients and ensure fair physician reimbursement.
  6. Ensure Appropriate Regulation of Artificial Intelligence (AI)
    Support innovation and patient safety in laboratory AI applications while maintaining the critical leadership role of pathologists in clinical decision-making.

The CAP welcomes the opportunity to partner with the new administration to advance these priorities in the months ahead, and hopes to schedule a meeting between CAP leadership and key members of the administration’s health policy team as a critical first step toward addressing these issues.

VB Divider

ABPath 2025 Board of Trustees and Officers. The American Board of Pathology (ABPath), a member board of the American Board of Medical Specialties, has announced its Board of Trustees and the election of officers for 2025.

"We appreciate our Trustees’ continued support, dedication, and willingness to serve as leaders in the profession of pathology, enabling the Board to fulfill its mission of serving the public and promoting excellence in the practice of pathology," ABPath said in the announcement.

ABPath trustees
The newly elected Executive Committee includes:

  • President: Mohiedean Ghofrani, MD, MBA, of Vancouver, WA
  • Vice President: Kathleen G. Beavis, MD, of Chicago, IL
  • Secretary: Matthew J. Wasco, MD, of Ann Arbor, MI
  • Treasurer: Mark K. Fung, MD, PhD, of Burlington, VT
  • Immediate Past President: Barbara A. Sampson, MD, PhD, of New York, NY

The following Trustees were re-elected to additional terms as Trustees:

  • Kathleen G. Beavis, MD to a second term
  • Jeffrey D. Goldstein, MD to a third term
  • Ritu Nayar, MD to a third term

In addition to the officers, the Trustees of the American Board of Pathology are:

  • Edward R. Ashwood, MD, of Aurora, CO
  • James R. Cook, MD, PhD, of Cleveland, OH
  • Jeffrey D. Goldstein, MD, of Los Angeles, CA
  • Julie D. Kingery, MD, of Gainesville, FL
  • Jennifer Laudadio, MD, of Little Rock, AR
  • Dylan Miller, MD, of Salt Lake City, UT
  • Ritu Nayar, MD, of Chicago, IL
  • Javarro Russell, PhD, of Richmond, VA

In the announcement, ABPath extended gratitude to Eric Glassy, MD, who completed his term as a Trustee in 2024. "Dr. Glassy’s expertise in digital pathology and emerging technologies has greatly contributed to advancing board certification in pathology,"  ABPath said.

A complete list of Trustees and their biographical information is available on the ABPath website

VB Divider

IMG_0148

Founded in 2002, Voicebrook is the leading provider of reporting solutions for pathology, with more than 550 client sites across the US, Canada, and Australia. 

Leverage the power of customized templates and the efficiency of speech recognition with VoiceOver PRO, a revolutionary reporting solution that's tailored to the unique needs of anatomic pathology.

SynoptIQ is a full-featured eCP solution solely focused on CAP cancer reporting, at a budget-friendly price point. SynoptIQ is where specificity and efficiency meet.

LEARN MORE

 

Pathology News Roundup: February 15, 2024

Pathology News Roundup: February 15, 2024

New CAP eCP Reporting Tool. There'sa new solution on the market designed to streamline CAP cancer reporting with unmatched accuracy and compliance.

Read More
Pathology News Roundup: August 15, 2024

Pathology News Roundup: August 15, 2024

Register for CAP24. It's hard to believe that the fall season is almost here... and that means CAP24 is just around the corner. Registration is now...

Read More
Pathology News Roundup: September 4, 2024

Pathology News Roundup: September 4, 2024

Battle Over FDA's LDT Rule Continues. The Association for Molecular Pathology (AMP) has filed a lawsuit against the FDA, challenging the Final Rule...

Read More